Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 14179K101 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
Nextech VII GP S.a r.l.
13G/A
Amendment 1
|
0% |
11/14/2025
Event 9/30/2025
|
|
| Nextech VII GP S.a. r.l. | 0% | ||
| Nextech VII Oncology SCSp | 0% | ||
| Ian Charoub | 0% | ||
| Costas Constantinides | 0% | ||
| Rocco Sgobbo | 0% | ||
|
Samsara BioCapital, L.P.
13G/A
Amendment 2
|
0% |
11/14/2025
Event 9/30/2025
|
|
| Samsara BioCapital, L.P. | 0% | ||
| Samsara BioCapital GP, LLC | 0% | ||
| Srinivas Akkaraju | 0% | ||
|
RTW Investments, LP
13G/A
Amendment 3
|
0% |
11/14/2025
Event 9/30/2025
|
|
| RTW Investments, LP | 0% | ||
| Roderick Wong | 0% | ||
|
Madison Avenue Partners, LP
13G/A
Amendment 2
|
0% |
11/14/2025
Event 9/30/2025
|
|
| Madison Avenue Partners, LP | 0% | ||
| Madison Avenue International LP | 0% | ||
| EMAI Management, LLC | 0% | ||
| Madison Avenue GP, LLC | 0% | ||
| Caraway Jackson Investments LLC | 0% | ||
| Eli Samaha | 0% | ||
|
Tang Capital Management LLC
13D/A
Amendment 2
|
100.0% |
8/21/2025
Event 8/19/2025
|
|
| Tang Capital Management, LLC | 100.0% | ||
| Kevin Tang | 100.0% | ||
| Tang Capital Partners, LP | 100.0% | ||
| Tang Capital Partners International, LP | 0% | ||
| Tang Capital Partners III, Inc | 0% | ||
| Tang Capital Partners IV, Inc | 0% | ||
| Concentra Biosciences, LLC | 100.0% | ||
| Concentra Merger Sub VII, Inc. | 0% | ||
|
RTW Investments, LP
13G/A
Amendment 2
|
6.4% |
8/14/2025
Event 6/30/2025
|
|
| RTW Investments, LP | 6.4% | ||
| Roderick Wong | 6.4% | ||
|
Madison Avenue Partners, LP
13G/A
Amendment 1
|
9.1% |
8/14/2025
Event 6/30/2025
|
|
| Madison Avenue Partners LP | 9.1% | ||
| Madison Avenue International LP | 9.1% | ||
| EMAI Management, LLC | 9.1% | ||
| Madison Avenue GP, LLC | 9.1% | ||
| Caraway Jackson Investments LLC | 9.1% | ||
| Eli Samaha | 9.1% | ||
|
FMR LLC
13G/A
Amendment 4
|
0% |
8/7/2025
Event 7/31/2025
|
|
| FMR LLC | 0% | ||
| Abigail P. Johnson | 0% | ||
|
FMR LLC
13G/A
Amendment 3
|
15.0% |
8/6/2025
Event 6/30/2025
|
|
| FMR LLC | 15.0% | ||
| Abigail P. Johnson | 15.0% | ||
|
Tang Capital Management LLC
13D/A
Amendment 1
|
6.6% |
7/9/2025
Event 7/7/2025
|
|
| Tang Capital Management, LLC | 6.6% | ||
| Kevin Tang | 6.6% | ||
| Tang Capital Partners, LP | 3.7% | ||
| Tang Capital Partners International, LP | 2.9% | ||
| Tang Capital Partners III, Inc | 0% | ||
| Tang Capital Partners IV, Inc | 0% | ||
| Concentra Biosciences, LLC | 0% | ||
|
Cormorant Asset Management, LP
13G
|
7.3% |
5/15/2025
Event 3/31/2025
|
|
| Cormorant Asset Management, LP | 7.3% | ||
| Bihua Chen | 7.3% | ||
| Janus Henderson Group PLC 13G/A Amendment 3 | 0% |
5/14/2025
Event 3/31/2025
|
|
| Price T Rowe Associates Inc /MD/ 13G/A Amendment 2 | 1.3% |
5/14/2025
Event 3/31/2025
|
|
|
FMR LLC
13G/A
Amendment 2
|
11.3% |
5/12/2025
Event 3/31/2025
|
|
| FMR LLC | 11.3% | ||
| Abigail P. Johnson | 11.3% | ||
|
Madison Avenue Partners, LP
13G
|
6.8% |
4/28/2025
Event 4/21/2025
|
|
| Madison Avenue Partners LP | 6.8% | ||
| Madison Avenue International LP | 6.8% | ||
| EMAI Management, LLC | 6.8% | ||
| Madison Avenue GP, LLC | 6.8% | ||
| Caraway Jackson Investments LLC | 6.8% | ||
| Eli Samaha | 6.8% | ||
|
Perceptive Advisors LLC
13G/A
Amendment 2
|
2.5% |
4/23/2025
Event 4/23/2025
|
|
| Perceptive Advisors LLC | 2.5% | ||
| Joseph Edelman | 2.5% | ||
| Perceptive Life Sciences Master Fund, Ltd. | 0% | ||
| Perceptive Xontogeny Venture Fund II, L.P. | 2.5% | ||
|
Tang Capital Management LLC
13D
|
5.9% |
2/21/2025
Event 2/13/2025
|
|
| Tang Capital Management, LLC | 5.9% | ||
| Kevin Tang | 5.9% | ||
| Tang Capital Partners, LP | 3.3% | ||
| Tang Capital Partners International, LP | 2.6% | ||
| Tang Capital Partners III, Inc | 0% | ||
| Tang Capital Partners IV, Inc | 0% | ||
| Concentra Biosciences, LLC | 0% | ||
| Janus Henderson Group PLC 13G/A Amendment 2 | 6.2% |
2/14/2025
Event 12/31/2024
|